Dynamic Contrast-Enhanced Magnetic Resonance Lymphangiography and Lymphatic Interventions for Pediatric Patients with Various Lymphatic Diseases

Y Ahn, HJ Koo, HM Yoon, J Choe, EY Joo… - Lymphatic Research …, 2023 - liebertpub.com
Y Ahn, HJ Koo, HM Yoon, J Choe, EY Joo, MH Song, DH Yang, JW Kang, JH Shin
Lymphatic Research and Biology, 2023liebertpub.com
Background: To demonstrate the magnetic resonance lymphangiography (MRL) imaging
findings of lymphatic diseases and the clinical outcomes of lymphatic embolization in
pediatric patients. Methods and Results: This retrospective study included 10 consecutive
pediatric patients who underwent MRL for lymphatic diseases between June 2017 and June
2021. Nine patients underwent dynamic contrast-enhanced MRL with bilateral inguinal
lymph node injection of diluted gadolinium, and one patient underwent nonenhanced MRL …
Background: To demonstrate the magnetic resonance lymphangiography (MRL) imaging findings of lymphatic diseases and the clinical outcomes of lymphatic embolization in pediatric patients.
Methods and Results: This retrospective study included 10 consecutive pediatric patients who underwent MRL for lymphatic diseases between June 2017 and June 2021. Nine patients underwent dynamic contrast-enhanced MRL with bilateral inguinal lymph node injection of diluted gadolinium, and one patient underwent nonenhanced MRL with a heavily T2-weighted image. The etiology of lymphatic disease was classified into three categories based on the magnetic resonance findings. The resolution of chylous fluid and weight-adjusted amounts of chylous fluid collected from a drainage tube were evaluated as outcomes. Patients were classified as postoperative lymphatic leak (n = 3), pulmonary lymphatic perfusion syndrome (n = 3), central lymphatic flow disorder (CLFD; n = 3), and primary lymphatic dysfunction (Gorham–Stout syndrome; n = 1). Three patients underwent radiological lymphatic intervention, and one CLFD patient underwent surgical intervention. In patients with postoperative lymphatic leak, the median chest tube drainage decreased significantly after the intervention [from 87.9 to 12.4 mL/(kg·d); p = 0.02]. However, in one CLFD patient, the amount of chylous fluid did not decrease until 7 days after intervention.
Conclusion: The etiology of lymphatic disease in pediatrics can be recognized on MRL, and lymphatic intervention can be performed for cessation of lymphatic leak, even though the treatment outcomes may differ according to the underlying etiology. MRL can play an important role in classifying lymphatic disease, and in planning treatment on the basis of the lymphatic anatomy and underlying etiology.
Mary Ann Liebert